Morgan Stanley
NUVL

Morgan Stanley’s Nuvalent NUVL Stock Holding History

Morgan Stanley’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Sell
200,790
-66,599
-25% -$6.79M ﹤0.01% 2934
2025
Q4 		$26.9M Sell
267,389
-7,721
-3% -$761K ﹤0.01% 2655
2025
Q3 		$23.8M Sell
275,110
-147,612
-35% -$11.7M ﹤0.01% 2726
2025
Q2 		$32.3M Buy
422,722
+74,642
+21% +$5.46M ﹤0.01% 2335
2025
Q1 		$24.7M Buy
348,080
+125,796
+57% +$9.84M ﹤0.01% 2484
2024
Q4 		$17.4M Sell
222,284
-249,433
-53% -$23.3M ﹤0.01% 2891
2024
Q3 		$48.3M Buy
471,717
+85,060
+22% +$7.06M ﹤0.01% 1850
2024
Q2 		$29.3M Buy
386,657
+201,986
+109% +$14.4M ﹤0.01% 2256
2024
Q1 		$13.9M Sell
184,671
-361,575
-66% -$28.8M ﹤0.01% 3066
2023
Q4 		$40.2M Buy
546,246
+374,013
+217% +$23.1M ﹤0.01% 2679
2023
Q3 		$7.92M Buy
172,233
+95,564
+125% +$4.24M ﹤0.01% 3336
2023
Q2 		$3.23M Buy
76,669
+4,198
+6% +$159K ﹤0.01% 4096
2023
Q1 		$1.89M Sell
72,471
-4,762
-6% -$141K ﹤0.01% 4493
2022
Q4 		$2.3M Buy
77,233
+19,481
+34% +$543K ﹤0.01% 4359
2022
Q3 		$1.12M Sell
57,752
-7,297
-11% -$122K ﹤0.01% 4817
2022
Q2 		$883K Buy
65,049
+40,394
+164% +$427K ﹤0.01% 5093
2022
Q1 		$342K Buy
24,655
+15,797
+178% +$229K ﹤0.01% 5606
2021
Q4 		$169K Buy
8,858
+7,940
+865% +$177K ﹤0.01% 6149
2021
Q3 		$21K Buy
+918
New +$26.6K ﹤0.01% 7079

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley's NUVL Position: Q1 2026 in Review

Morgan Stanley reduced its Nuvalent (NUVL) stake by 25% in Q1 2026, selling an estimated $6.79M and leaving 200,790 shares worth $20.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

Morgan Stanley first reported a position in NUVL in Q3 2021 and has held it in 19 quarters since. The position peaked at $48.3M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Morgan Stanley held 200,790 shares of Nuvalent worth $20.6M as of Q1 2026.
  • Morgan Stanley sold 66,599 Nuvalent shares in Q1 2026, an estimated $6.79M.
  • Nuvalent made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #2934 holding.
  • Morgan Stanley first reported a position in Nuvalent in Q3 2021 and has held it in 19 quarters since.
  • Morgan Stanley's Nuvalent position peaked at $48.3M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.